Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 4744

1.

Crystal Engineering of Self-Assembled Porous Protein Materials in Living Cells.

Abe S, Tabe H, Ijiri H, Yamashita K, Hirata K, Atsumi K, Shimoi T, Akai M, Mori H, Kitagawa S, Ueno T.

ACS Nano. 2017 Jan 17. doi: 10.1021/acsnano.6b06099. [Epub ahead of print]

PMID:
28094987
2.

Increased pre-procedural urinary microalbumin is associated with a risk for renal functional deterioration after coronary computed tomography angiography.

Isobe S, Yuba M, Mori H, Suzuki S, Sato K, Ishii H, Murohara T.

Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34535-1. doi: 10.1016/j.ijcard.2016.12.049. [Epub ahead of print]

PMID:
28057367
3.

Strain-specific transmission in an outbreak of ESBL-producing Enterobacteriaceae in the hemato-oncology care unit: a cohort study.

Uemura M, Imataki O, Uchida S, Nakayama-Imaohji H, Ohue Y, Matsuka H, Mori H, Dobashi H, Kuwahara T, Kadowaki N.

BMC Infect Dis. 2017 Jan 5;17(1):26. doi: 10.1186/s12879-016-2144-4.

4.

Gender Difference of Gastric Emptying in Healthy Volunteers and Patients with Functional Dyspepsia.

Mori H, Suzuki H, Matsuzaki J, Taniguchi K, Shimizu T, Yamane T, Masaoka T, Kanai T.

Digestion. 2017;95(1):72-78. doi: 10.1159/000452359.

PMID:
28052285
5.

Current Status of Exposed Endoscopic Full-Thickness Resection and Further Development of Non-Exposed Endoscopic Full-Thickness Resection.

Mori H, Rahman A, Kobara H, Fujihara S, Nishiyama N, Ayaki M, Matsunaga T, Murakami M, Masaki T.

Digestion. 2017;95(1):6-15. doi: 10.1159/000452352.

6.

The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo.

Fujihara S, Morishita A, Ogawa K, Tadokoro T, Chiyo T, Kato K, Kobara H, Mori H, Iwama H, Masaki T.

Oncotarget. 2016 Dec 28. doi: 10.18632/oncotarget.14345. [Epub ahead of print]

7.

Zoonotic potential of Enterocytozoon genotypes in humans and pigs in Thailand.

Prasertbun R, Mori H, Pintong AR, Sanyanusin S, Popruk S, Komalamisra C, Changbunjong T, Buddhirongawatr R, Sukthana Y, Mahittikorn A.

Vet Parasitol. 2017 Jan 15;233:73-79. doi: 10.1016/j.vetpar.2016.12.002.

PMID:
28043391
8.

Nipple Reconstruction with Dorsal Skin Provides Better Projection than Reconstruction with Abdominal or Breast Skin with Cartilage Grafting.

Mihara R, Mori H, Okazaki M.

Aesthetic Plast Surg. 2016 Dec 30. doi: 10.1007/s00266-016-0733-7. [Epub ahead of print]

PMID:
28039502
9.

Aortic Pseudoaneurysm due to Simple Vertebral Compression Fracture Treated with Conservative Management.

Ishii H, Nakamura K, Nakamura E, Endo G, Furukawa K, Shirasaki Y, Mori H.

Ann Vasc Dis. 2016;9(4):349-351. doi: 10.3400/avd.cr.16-00030.

10.

Myeloperoxidase in blood neutrophils during normal and abnormal menstrual cycles in women of reproductive age.

Shibata T, Sakamoto J, Osaka Y, Neyatani N, Fujita S, Oka Y, Takagi H, Mori H, Fujita H, Tanaka Y, Sasagawa T.

Int J Lab Hematol. 2016 Dec 25. doi: 10.1111/ijlh.12599. [Epub ahead of print]

PMID:
28013526
11.

The Involvement of Hepatocyte Growth Factor-MET-Matrix Metalloproteinase 1 Signaling in Bladder Cancer Invasiveness and Proliferation. Effect of the MET Inhibitor, Cabozantinib (XL184), on Bladder Cancer Cells.

Shintani T, Kusuhara Y, Daizumoto K, Dondoo TO, Yamamoto H, Mori H, Fukawa T, Nakatsuji H, Fukumori T, Takahashi M, Kanayama H.

Urology. 2016 Dec 21. pii: S0090-4295(16)30945-1. doi: 10.1016/j.urology.2016.12.006. [Epub ahead of print]

PMID:
28013036
12.

Galectin-3 Is Implicated in Tumor Progression and Resistance to Anti-androgen Drug Through Regulation of Androgen Receptor Signaling in Prostate Cancer.

Dondoo TO, Fukumori T, Daizumoto K, Fukawa T, Kohzuki M, Kowada M, Kusuhara Y, Mori H, Nakatsuji H, Takahashi M, Kanayama HO.

Anticancer Res. 2017 Jan;37(1):125-134.

PMID:
28011482
13.

Phylogenomics and Morphology of Extinct Paleognaths Reveal the Origin and Evolution of the Ratites.

Yonezawa T, Segawa T, Mori H, Campos PF, Hongoh Y, Endo H, Akiyoshi A, Kohno N, Nishida S, Wu J, Jin H, Adachi J, Kishino H, Kurokawa K, Nogi Y, Tanabe H, Mukoyama H, Yoshida K, Rasoamiaramanana A, Yamagishi S, Hayashi Y, Yoshida A, Koike H, Akishinonomiya F, Willerslev E, Hasegawa M.

Curr Biol. 2017 Jan 9;27(1):68-77. doi: 10.1016/j.cub.2016.10.029.

PMID:
27989673
14.

BRCAness as a Biomarker for Predicting Prognosis and Response to Anthracycline-Based Adjuvant Chemotherapy for Patients with Triple-Negative Breast Cancer.

Mori H, Kubo M, Nishimura R, Osako T, Arima N, Okumura Y, Okido M, Yamada M, Kai M, Kishimoto J, Miyazaki T, Oda Y, Otsuka T, Nakamura M.

PLoS One. 2016 Dec 15;11(12):e0167016. doi: 10.1371/journal.pone.0167016.

15.

TCT-836 Endothelial Cell Coverage and Inflammation Comparing COBRA Polyzene-F (PzF) Coated Stent to Durable Fluoropolymer and Biodegradable Polymer Drug-Eluting Stents in a Rabbit Model.

Yahagi K, Kolodgie F, Cheng D, Acampado E, Mori H, Chinnakondepali K, Romero M, Finn A, Virmani R.

J Am Coll Cardiol. 2016 Nov 1;68(18S):B338. doi: 10.1016/j.jacc.2016.09.865. No abstract available.

PMID:
27970227
16.

TCT-835 Endothelial Function Assessed by Expression of Adherens Junctions and Inflammation between Durable and Biodegradable Polymer Drug-Eluting Stents in the Rabbit Iliofemoral Model.

Yahagi K, Kolodgie F, Cheng D, Acampado E, Guo L, Mori H, Chinnakondepali K, Romero M, Perkins L, Finn A, Virmani R.

J Am Coll Cardiol. 2016 Nov 1;68(18S):B337-B338. doi: 10.1016/j.jacc.2016.09.864. No abstract available.

PMID:
27970224
17.

TCT-468 Acute Thrombogenicity and Inflammation in Response to a Durable Fluoropolymer Everolimus-Eluting Stent Relative to a Contemporary Sirolimus-Eluting Stent with an Abluminal Biodegradable Polymer Coating.

Torii S, Kolodgie F, Cheng D, Acampado E, Yahagi K, Mori H, Romero M, Perkins L, Hossainy S, Pacetti S, Finn A, Virmani R.

J Am Coll Cardiol. 2016 Nov 1;68(18S):B188. doi: 10.1016/j.jacc.2016.09.604. No abstract available.

PMID:
27969825
18.

TCT-465 Everolimus eluting stents increase endothelial permeability and prevent maturation - Uncovering the mechanism of Neoatherosclerosis.

Harari E, Kolodgie F, Acampado E, Guo L, Mori H, Kutyna M, Finn A, Virmani R.

J Am Coll Cardiol. 2016 Nov 1;68(18S):B187. doi: 10.1016/j.jacc.2016.09.601. No abstract available.

PMID:
27969821
19.

TCT-455 Long-term (≥1 year) Pathological Result of Everolimus-eluting versus Sirolimus-eluting and Bare Metal Stents.

Mori H, Torii S, Yahagi K, Harari E, Kutys R, Romero M, Virmani R, Finn A.

J Am Coll Cardiol. 2016 Nov 1;68(18S):B183. doi: 10.1016/j.jacc.2016.09.591. No abstract available.

PMID:
27969810
20.

TCT-446 Fluoropassivation of Coronary Stents as a Potential Mechanism of Improved Thromboresistance.

Torii S, Kolodgie F, Cheng D, Acampado E, Yahagi K, Mori H, Romero M, Perkins L, Hossainy S, Pacetti S, Finn A, Virmani R.

J Am Coll Cardiol. 2016 Nov 1;68(18S):B179-B180. doi: 10.1016/j.jacc.2016.09.582. No abstract available.

PMID:
27969800
Items per page

Supplemental Content

Support Center